Ronald Kirk Huntsman - 15 Jun 2023 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role
Chief Executive Officer, Director
Signature
/s/ Brad Amman as attorney-in-fact for R. Kirk Huntsman
Issuer symbol
VVOS
Transactions as of
15 Jun 2023
Net transactions value
+$8,060
Form type
4
Filing time
20 Jun 2023, 06:10:09 UTC
Previous filing
15 Jun 2023
Next filing
20 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VVOS Common Stock Purchase $10.5 +21 +0.04% $0.5000 57,521 15 Jun 2023 Direct
transaction VVOS Common Stock Purchase $5,400 +10,000 +17% $0.5400 67,521 16 Jun 2023 Direct
transaction VVOS Common Stock Purchase $2,650 +5,000 +7.4% $0.5300 72,521 16 Jun 2023 Direct
holding VVOS Common Stock 1,740,000 15 Jun 2023 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.